Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vincent Jenkins

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Blood Reviews|December 2, 2004
Mutating factor VIII: lessons from structure to functionPhilip J Fay, P Vincent Jenkins
British Journal of Haematology|March 4, 2006
Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytesHélène Hochart, P Vincent Jenkins, Owen P Smith, et al.
Biochemistry|April 28, 2004
Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor XaseP Vincent Jenkins, Julie L Dill, Qian Zhou, et al.
The Biochemical Journal|March 1, 2006
Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIaFatbardha Varfaj, Julie Neuberg, P Vincent Jenkins, et al.
Blood|July 2, 2002
Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complexP Vincent Jenkins, Jan Freas, Kyla M Schmidt, et al.
European Journal of Human Genetics : EJHG|June 10, 2011
Clinical utility gene card for: haemophilia ASteve Keeney, Tony Cumming, P Vincent Jenkins, et al.
European Journal of Human Genetics : EJHG|January 6, 2011
Clinical utility gene card for: von Willebrand diseaseAnthony M Cumming, Stephen Keeney, P Vincent Jenkins, et al.
Thrombosis and Haemostasis|March 11, 2008
Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole bloodHelene Hochart, P Vincent Jenkins, Roger J S Preston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2019
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guidelineElaine Gray, Steve Kitchen, Annette Bowyer, et al.
British Journal of Haematology|February 14, 2002
Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assayAnne F Riddell, P Vincent Jenkins, Ioana C Nitu-Whalley, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood Reviews|December 2, 2004
Mutating factor VIII: lessons from structure to functionPhilip J Fay, P Vincent Jenkins
British Journal of Haematology|March 4, 2006
Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytesHélène Hochart, P Vincent Jenkins, Owen P Smith, et al.
Biochemistry|April 28, 2004
Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor XaseP Vincent Jenkins, Julie L Dill, Qian Zhou, et al.
The Biochemical Journal|March 1, 2006
Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIaFatbardha Varfaj, Julie Neuberg, P Vincent Jenkins, et al.
Blood|July 2, 2002
Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complexP Vincent Jenkins, Jan Freas, Kyla M Schmidt, et al.
European Journal of Human Genetics : EJHG|June 10, 2011
Clinical utility gene card for: haemophilia ASteve Keeney, Tony Cumming, P Vincent Jenkins, et al.
European Journal of Human Genetics : EJHG|January 6, 2011
Clinical utility gene card for: von Willebrand diseaseAnthony M Cumming, Stephen Keeney, P Vincent Jenkins, et al.
Thrombosis and Haemostasis|March 11, 2008
Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole bloodHelene Hochart, P Vincent Jenkins, Roger J S Preston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2019
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guidelineElaine Gray, Steve Kitchen, Annette Bowyer, et al.
British Journal of Haematology|February 14, 2002
Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assayAnne F Riddell, P Vincent Jenkins, Ioana C Nitu-Whalley, et al.
Pageof 2